LAFUVITUG
UNII IS3OH21U4J

Substance Identification & Data

This profile provides standardized clinical and technical data for Lafuvitug, uniquely identified by the FDA Unique Ingredient Identifier (UNII) IS3OH21U4J.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2743342-91-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

IS3OH21U4J

CAS Registry Number

2743342-91-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LAFUVITUG

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C199008

National Cancer Institute reference terminology for clinical and research data.

INN ID

12541

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lafuvitug. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LAFUVITUG

Common Names & Synonyms

GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-453) (VH (HOMO SAPIENS IGHV1-2*02 (62.7%) -(IGHD) -IGHJ3*01 (85.7%), CDR-IMGT (8.8.12) (26-33.51-58.101-112), FR3 INSERTION D84.1, F84.2, D85.2, T85.1 (77-80))(1-123) -HOMO SAPIENS IGHG1*01 (100%), G1M17,1 CH1 K120, CH3D12, L14 (CH1 K120 (220) (124-221), HINGE 1-15 (222-236), CH2 (237-346), CH3 D12 (362), L14 (364) (347-451), CHS (452-453)) (124-453)),(226-206')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'-206') (V-KAPPA (HOMO SAPIENS IGKV1-33*01 (72.8%) -IGKJ5*01 (41,6%)DEL(F118, G119, Q120) 92^93, E125>D (97), I126>L (98), CDR-IMGT(2.3.8) (27-28.46-48.85-92)) (1'-99') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (145), V101 (183) (100'-206')); DIMER (232-232'':235-235'')- BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHOK1SV, GLYCOFORM ALFA

IMMUNOGLOBULIN G1, ANTI-(HUMAN IMMUNODEFICIENCY VIRUS 1 ENVELOPE GLYCOPROTEIN GP120ENV CD4-BINDING SITE) (HUMAN MONOCLONAL 3BNC117 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 3BNC117 .KAPPA.-CHAIN, DIMER

LAFUVITUG [INN]